Drug intelligence / Profile preview

live escherichia coli vaccine

Development stage: Preclinical
Lead developer: EnWave
Modality: Vaccines & Immunotherapeutics
Administration: Oral

Overview

A live *Escherichia coli* vaccine developed for animal use. The development efforts are focused on enhancing its preservation through innovative dehydration technologies, such as EnWave's freezeREV™ prototype. This technology aims to drastically reduce the drying time compared to conventional freeze-drying methods, while maintaining comparable bacterial survival and improving vaccine stability, particularly at elevated temperatures.

Other names: live E. coli animal vaccine

Beyond the preview

Go deeper on live escherichia coli vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on live escherichia coli vaccine.

Explore the full profile